Triplet Therapy Strategies Signal a Shift in Relapsed Follicular Lymphoma Care
- February 11, 2026
How Anemia Could Signal a Rare Blood Cancer
Optic Nerve Stem Cells Redraw the Map of Retinal Vascular Repair
Datroway Receives U.S. Priority Review for First‑Line Treatment of Metastatic Triple‑Negative Breast Cancer
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Heart failure doesn’t happen overnight — and many risk factors are preventable.
This Heart Failure Awareness Week is a reminder that what we do today can protect our hearts tomorrow. Prevention starts early, awareness matters, and proactive choices can make a real difference. ❤️ #HeartFailureAwarenessWeek #HeartFailure #HeartHealthy #PatientWorthy
Rare disease doesn’t just affect the body.
It reshapes relationships, routines, goals, timelines, and the way success is defined.
For many in this community, progress looks different than it once did — and that doesn’t make it less meaningful.
This month, we’re not only raising awareness of diagnoses.
We’re raising awareness of the lived experience.
If you see yourself in this post, you’re not alone.
And your version of progress still counts.
#RareDiseaseMonth #RareDisease #RareButNotAlone #WeCareAboutRare #ShareYourStripes #ShareYourStory #PatientWorthy
Relapsed Follicular Lymphoma can be tricky to treat, but a new review shows that a "triplet" approach could be the most promising. Read more here:
patientworthy.com/2026/02/11/triplet-therapy-strategies-signal-a-shift-in-relapsed-follicular-lym...
